Digestive discomfort is one of the most frequently reported side effects when women start or ramp up GLP-1 therapies. Nausea, bloating, diarrhoea, constipation, and delayed gastric emptying are all part of the adaptation that many experience.
At HerVibe, our goal is to support the body through transformation - not fight against it. That’s why we included DigeZyme®, a thoughtfully formulated enzyme blend, in our product line. It aligns with our philosophy of subtle, science-driven support, especially when the body’s digestion is in flux.
Below, you’ll find the breakdown: what DigeZyme does, how it may help with GLP-1 digestive side effects, and how we position it within our formulas.
What Is DigeZyme?
DigeZyme® (from the Sabinsa/Prinova family of branded ingredients) is a multienzyme complex that combines five digestive enzymes:
Enzyme - Breakdown Target/Function
α-amylase - Carbohydrates/starch → simpler sugars
Protease - Proteins → peptides / amino acids
Lipase - Fats / lipids → fatty acids & glycerol
Lactase - Lactose (milk sugar) → glucose + galactose
Cellulase - Cellulose/plant fibre components (aiding breakdown of fibre & plant cell walls)
In human clinical investigations, DigeZyme has been shown to support improved digestion, reduced digestive discomfort, and enhanced nutrient absorption.
Because it covers multiple macronutrient classes (carbs, fats, proteins) and even fibre/lactose, it's a broad-spectrum support - not a single-target enzyme.
Common Digestive Side Effects of GLP-1 Therapies
Before delving into how DigeZyme may help, it’s important to understand what kinds of GI (gastrointestinal) issues many people report when on GLP-1 therapies.
Some of the most common symptoms include:
- Nausea - one of the most frequently reported side effects.
- Vomiting / Upper GI upset
- Diarrhoea or loose stools - shifts in bowel consistency are common.
- Constipation or slowed transit - because GLP-1 slows gastric emptying and intestinal motility in many patients.
- Bloating, gas, fullness/discomfort
- Delayed gastric emptying/gastroparesis risk - in rare but documented cases.
In fact, GI adverse events occur in as many as 40–70% of people using GLP-1 therapies (in clinical trials), especially during dose escalation.
Because GLP-1 agents slow down digestion (via delayed gastric emptying), the digestive “load” on the system changes. Food may sit longer in the stomach, digestive enzyme exposure time is modified, and nutrient breakdown/absorption demands shift.
How DigeZyme May Help Support a Smoother Adaptation
Given the challenges above, here’s how DigeZyme may play a supportive role for women on GLP-1 therapy:
-
Reducing the digestive workload
When the GI tract is “slower,” endogenous enzyme production or distribution may lag relative to the demand. Supplementing with exogenous enzymes helps pre-digest macronutrients so that the body’s system doesn’t have to overcompensate. -
Smoothing macronutrient breakdown
Since DigeZyme contains protease, lipase, α-amylase, and cellulase, it supports the breakdown of proteins, fats, carbs, and plant fibres. That means less unprocessed substrate lingering in the gut, which can reduce gas, bloating, and discomfort. -
Handling dairy/lactose challenges
For those who may simultaneously reduce other foods or change diet patterns while on GLP-1, lactose intolerance or mild lactose sensitivity sometimes surfaces. The lactase component helps with the digestion of lactose. -
Supporting nutrient absorption
Enhanced digestion means nutrients are more bioavailable. Over time, better absorption supports energy, recovery, and overall wellness - critical as someone is undergoing metabolic / weight adaptation. -
Gentle support, not a “rescue”
DigeZyme is not a laxative or a drug. It doesn’t force motility or accelerate transit. Instead, it gently supports natural digestive function without overstimulation, which aligns with HerVibe’s “quiet support” philosophy.
How We Use DigeZyme in HerVibe Formulas & Positioning
Synergy with other components
In HerVibe, DigeZyme complements postbiotics (like BetaVia Complete), prebiotic fibres, and gut-nourishing ingredients. Together, they aim to support both the mechanical and immunological sides of digestion.
Dosage & pragmatics
We dose DigeZyme within clinically studied ranges (mirroring the amounts used in human enzyme-support trials) to maximise efficacy while minimising risk or over-enzyme “imbalance.”